Metabolic Syndrome Criteria and the Effect of Testosterone Treatment in Young Men With Hypogonadism

Gulhane School of Medicine

Status and phase: Completed; Phase 4

Conditions: Hypogonadism

Treatments: Drug: Testosteron

Study type: Interventional

Funder types: Other

Identifiers

NCT01160341

GSM-072010

Details and patient eligibility

About

The study is designed to answer the following questions:

1. Is hypogonadism a cause for the metabolic syndrome ?
2. What is the effect of testosterone replacement on the metabolic parameters ?

Full description

This is a retrospective design, which is performed by investigating the registrations of patients with hypogonadotrophic hypogonadism between the years 2002-2009.

Enrollment: 312 patients

Sex: Male

Ages: 18 to 26 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Men
• Congenital hypogonadism
• Treatment Naive

Exclusion criteria

• Previous history of androgen replacement
• Hypertension
• Diabetes mellitus

Trial design

Primary purpose: Screening

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

312 participants in 1 patient group

Testosteron, secondary hypogonadism

Experimental group

Treatment:

Drug: Testosteron